Clinical Trials Browser

Phase 3 × OTHER × shengxuening × Clear all

NCT05784870 2023-08-25

A Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic Tumors

Phase 3 Unknown

Other hematologic neoplasm

Hematologic Neoplasms